ACROSS DOWN
1. _____ or biotherapy is the therapeutic use of agents derived from biologic sources and/or affecting biologic responses.
3. Bortezomib is administered to patients with multiple _____ who have received two prior therapies and who have shown disease progression since the last therapy.
6. Hematopoietic growth factors are a biotherapy class of proteins that communicate with specific receptors to control the production, maturation, and function of _____ cells. 14. Monoclonal antibodies ending in "zumab" 1. Biotherapy alters the body's _____ response, resulting in therapeutic effects.
2. Administration of interleukin-2 is FDA approved for _____ cell cancer and metastatic melanoma.
4. Erythropoietin alpha is a hematopoietic growth factor and a glycoprotein that stimulates _____ blood cell production. 
